Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma-Cell Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Early research (Phase 1)Study completedNCT00025415
What this trial is testing

Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAIDS-related Peripheral/Systemic Lymphoma+78 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Looking for participantsNCT07681596
What this trial is testing

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
AstraZeneca 101
Early research (Phase 1)Ended earlyNCT01643603
What this trial is testing

Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies

Who this might be right for
Non-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more
Barbara Ann Karmanos Cancer Institute 5
Large-scale testing (Phase 3)Study completedNCT00452569
What this trial is testing

Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 499
Early research (Phase 1)Ended earlyNCT02030483
What this trial is testing

Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 9
Testing effectiveness (Phase 2)Study completedNCT02917941
What this trial is testing

Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapsed and/or Refractory Multiple Myeloma
Takeda 34
Testing effectiveness (Phase 2)WithdrawnNCT01479582
What this trial is testing

Providing Access to Cord Blood Units for Transplants

Who this might be right for
Chronic Myelogous Leukemia/Other LeukemiaAcute LeukemiasMDS/MPS+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT03506386
What this trial is testing

Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis

Who this might be right for
Multiple Myeloma
Takeda 943
Early research (Phase 1)Study completedNCT00871910
What this trial is testing

Phase 1 Every-3-Week Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04630)

Who this might be right for
Solid TumorsLymphoma, Non-HodgkinMultiple Myeloma
Merck Sharp & Dohme LLC 81
Early research (Phase 1)Ended earlyNCT06588660
What this trial is testing

ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
University of Washington 1
Not applicableStudy completedNCT01929720
What this trial is testing

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

Who this might be right for
Anxiety DisorderWorryUncertainty+19 more
Ohio State University Comprehensive Cancer Center 33
Testing effectiveness (Phase 2)UnknownNCT03670173
What this trial is testing

Safety and Efficacy Assessments of Osalmid in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Shanghai 10th People's Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT05050305
What this trial is testing

Marizomib Central Nervous System (CNS)

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma, Refractory
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07479979
What this trial is testing

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Natalie Callander 62
Early research (Phase 1)Study completedNCT00301951
What this trial is testing

Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
University of California, San Francisco 7
Not applicableStudy completedNCT06063603
What this trial is testing

Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study

Who this might be right for
Chronic LeukemiaHematopoietic and Lymphoid System NeoplasmLymphoma+2 more
Mayo Clinic 51
Not applicableStudy completedNCT04589286
What this trial is testing

Randomized Study of Digital Life Coaching in Myeloma Patients Undergoing Transplantation

Who this might be right for
Multiple MyelomaStem Cell Transplant
University of California, San Francisco 60
Testing effectiveness (Phase 2)UnknownNCT03605056
What this trial is testing

Phase 2 Trial of Chidamide-Lenalidomide-Dexamethasone(CRD) Regimen in R/R MM

Who this might be right for
Multiple Myeloma
Peng Liu 25
Testing effectiveness (Phase 2)Ended earlyNCT00113646
What this trial is testing

Non-Myeloablative HLA-Mismatched Ex-Vivo T-cell Depleted Stem Cell Transplantation for Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma+1 more
Massachusetts General Hospital 14
Next Page